Earth Science Tech (ETST) Free Cash Flow Growth (1y) (2012 - 2026)
Earth Science Tech (ETST) Free Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn | 44.93% |
| 10 | Earth Science Tech | 32.24 Mn | 30.08 Mn | 6.27 Mn | -62.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.36% |
| Dec 31, 2025 | -212.58% |
| Sep 30, 2025 | -27.30% |
| Jun 30, 2025 | -108.37% |
| Mar 31, 2025 | 126.24% |
| Dec 31, 2024 | -15.26% |
| Sep 30, 2024 | 401.09% |
| Jun 30, 2024 | 1,697.53% |
| Mar 31, 2024 | 361.42% |
| Dec 31, 2023 | 161.11% |
| Sep 30, 2023 | 151.66% |
| Jun 30, 2023 | -123.32% |
| Mar 31, 2023 | -169.40% |
| Dec 31, 2022 | -1,395.17% |
| Sep 30, 2022 | -2,391.24% |
| Jun 30, 2022 | 33.45% |
| Mar 31, 2022 | -212.39% |
| Dec 31, 2021 | 69.39% |
| Sep 30, 2021 | 130.94% |
| Jun 30, 2021 | 14.01% |